MD Anderson Unveils Wave of Cancer Breakthroughs From Lung Immunotherapy to Microbiome Medicine
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in ...
Tag: B7-H3
Why Antigen Expression Alone Cannot Predict Response to B7-H3-Targeted Cancer Therapy
A new review argues that B7-H3 positivity measured by immunohistochemistry is necessary but not sufficient to predict response to antibody-drug ...
Scientists Map a Battle Plan Against One of Medicine’s Rarest and Deadliest Childhood Cancers
An international expert workshop has prioritised targets and trial designs to break the three-decade therapeutic stalemate in desmoplastic small round ...
Immune Molecule B7-H3 Drives Triple-Negative Breast Cancer Through a Hidden Protein Machinery
New research reveals that the immune checkpoint protein B7-H3 fuels triple-negative breast cancer from within by sustaining SP1-dependent HSPA8 chaperone ...
Immune Checkpoint VISTA Doubles as a Growth Engine Inside Mesothelioma Cells
New research shows the immune checkpoint molecule VISTA also drives proliferation within mesothelioma cells through RIPK1-associated and AKT-dependent signalling, making ...
FDA Clears Trial of Dual-Target CAR T-Cell Therapy for Colorectal Cancer
The FDA has cleared a CU Anschutz clinical trial testing dual-target CAR T-cell therapy against advanced colorectal cancer and pediatric ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!